Franklin Resources Inc. Acquires Shares of 19,908 Astrana Health, Inc. (NASDAQ:ASTH)

Franklin Resources Inc. bought a new position in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 19,908 shares of the company's stock, valued at approximately $1,187,000.

A number of other hedge funds also recently added to or reduced their stakes in ASTH. GAMMA Investing LLC bought a new stake in Astrana Health during the 3rd quarter valued at $34,000. Nisa Investment Advisors LLC bought a new stake in shares of Astrana Health during the third quarter valued at about $35,000. KBC Group NV bought a new stake in shares of Astrana Health during the third quarter valued at about $70,000. Quarry LP acquired a new stake in Astrana Health in the third quarter worth about $77,000. Finally, Quest Partners LLC bought a new position in Astrana Health in the 3rd quarter valued at about $133,000. 52.77% of the stock is currently owned by institutional investors.

Astrana Health Price Performance

Shares of ASTH traded down $0.81 during trading hours on Friday, hitting $32.72. 235,126 shares of the company were exchanged, compared to its average volume of 218,009. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. The company has a market capitalization of $1.84 billion, a PE ratio of 25.17, a PEG ratio of 1.80 and a beta of 1.13. The firm has a fifty day simple moving average of $44.45 and a 200-day simple moving average of $47.62. Astrana Health, Inc. has a one year low of $32.21 and a one year high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting analysts' consensus estimates of $0.33. The business had revenue of $478.71 million during the quarter, compared to analyst estimates of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same quarter last year, the company posted $0.47 EPS. As a group, sell-side analysts predict that Astrana Health, Inc. will post 1.16 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have commented on ASTH shares. Macquarie upgraded shares of Astrana Health to a "hold" rating in a research report on Monday, December 16th. Robert W. Baird boosted their target price on Astrana Health from $67.00 to $86.00 and gave the stock an "outperform" rating in a report on Wednesday, November 13th. TD Cowen initiated coverage on Astrana Health in a research report on Monday, October 14th. They issued a "buy" rating and a $66.00 target price for the company. KeyCorp assumed coverage on Astrana Health in a research report on Friday, October 11th. They set a "sector weight" rating on the stock. Finally, BTIG Research upped their price objective on Astrana Health from $60.00 to $70.00 and gave the company a "buy" rating in a report on Thursday, October 3rd. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $65.17.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.